TherapeuticsMD
TXMD
TXMD
153 hedge funds and large institutions have $200M invested in TherapeuticsMD in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
-6
Holders Change %
-3.77%
% of All Funds
2.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
49
Reduced
38
Closed
23
Calls
$2.01M
Puts
$865K
Net Calls
+$1.15M
Net Calls Change
+$132K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.43M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.35M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.16M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.43M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$747K |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$3.69M |
| 2 |
BlackRock
New York
|
-$3.28M |
| 3 |
Axa
Paris,
France
|
-$2.54M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$2.15M |
| 5 |
Goldman Sachs
New York
|
-$1.88M |
